(Q34577699)
Statements
1 reference
An evaluation of the FDA responder endpoint for IBS-C clinical trials: analysis of data from linaclotide Phase 3 clinical trials (English)
1 reference
J E Macdougall
1 reference
J M Johnston
1 reference
B J Lavins
1 reference
L M Nelson
1 reference
V S L Williams
1 reference
R T Carson
1 reference
S J Shiff
1 reference
K Shi
1 reference
C B Kurtz
1 reference
M J Baird
1 reference
M G Currie
1 reference
A J Lembo
1 reference
6 February 2013
1 reference
1 reference
25
1 reference
6
1 reference
481-486
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference